Biotech giant Amgen looks to out-license technology

You are here: Home > Biotech > Current Article

Amgen looks to out-license new technologies to partners

By Marissa Nall / Friday, March 22nd, 2019 / Comments Off on Amgen looks to out-license new technologies to partners

A statue of Amgen co-founder William K. Bowes Jr. stands watch over the Thousand Oaks campus. From its headquarters in Thousand Oaks, Amgen’s scientists are scouring the world for new technologies to license and acquire. But the next big biotech firm in the Conejo Valley could come from projects gathering dust on Amgen’s intellectual property…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.